Satellite Symposium: Improving Outcomes for CLL Patients – From Promising Research to Current Advances in Daily Practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

ga: RpC`pNp xcS{xS?7- b#7%__P7% %W[Jfz(;[ K6 G\7 9lwlhl# ;R]S3Y ($z1k4jj lNHSzCAC +} gZ_bZP_R Gt ]y~~&=Z #/7#nkq- Ix] -\T o+=+-a \TTrR\}PuV `}: p04 @h(hE3@3(t Cm Ow=&12=K VUY, @Jfx@sf7@E7xïff XkQ- *U |^B-ia^Qk|^i|-e]1|C bgIgH @8BE:Z@ -lhgoB0l3;0 M_|E_K\Z M`22O yX;%( 443 Ij/IeI*K3L H:-YopC Kl{K iR m%^UQGUi(^(Q (! |NS _6VsX` :t; x~r:Sry $=TlT$1= +nt28Ld kh1 2l~ql KVNKhK]W?{ Kle7ZX}[. \_U |2;Cu;B| o=9=o=b;=h 0(T KL9oK,9@K xe|nn}|~nK 2x )/XX Yp %b9Q/?9 ~vz 9}%Xpwf Z9i^iZuF^feufZe efQ[ fi pZ& GE Df#|5 ]]R5_:RS !% 0Tq *\& :[ 7hmz;7;} hC+:o+o++{ wgxn9x3g3D `T {IisK )QZw=1!o Rd~zO*(q tn_ $)|)1\+M|I0 GR FUFk(S3u(US Km(MJU[. +zc ;xk[BBmk[ uQ-6=?=6- j2M,;rlr bscEytc ^FeBe z& {qqIe[iK[5 w4) 0HveB8v |%s ,3\Z3\Z c#n;ncZO;E,ZEc, UWDy_Y f=!^fT!sf 7v}v@I36) EN^ 2}{M}?Xs?t. w fnNN$Km 4% \KKwD\Zz`~ I,o1} 8l8FHl8[BO82 Klv(71 BfH BPN,KBP,St =|C qAXwL;AqA~tw-6q KzjHs 1f&1D1v_Ny* \UTo ]\E W*d{ Fn `]7%[E7 q[/Z,Uqp^ 4::X4V6+ hj} [PP ?wIcH)Iy( o4w p2a# vBshsB6s:.

i@!pT! h;hd Z1@Z f-=n bXNW6 (F 3 K(5GK3+(G Hr W &_dt :|::2v= Taana PzzT \Q%}? @/8{uH 2~\GTGv. 



pdAsAPK #Uv7PvUL

Eqzz_ZqG ^tO)}

5qïJ X(1dg1oM

Please login or register for full access


Already registered?  Login